PUMA Concludes Season One of Industry-first Sustainability Report Podcast Series
1.8.2023 10:57:00 EEST | Business Wire | Press release
The final episode of PUMA’s RE:GEN REPORTS is now available to stream: ‘When it comes to Health and Safety, does the West know best?’. In this episode, hosted by the Head of Knowledge Exchange at the Centre for Sustainable Fashion, Monica Buchan-Ng, PUMA’s Chief Sourcing Officer, Anne-Laure Descours, reminds audiences that it’s important for people in the North to “recognize how much people on the ground are trying to improve [factory working conditions].”
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230801314932/en/
The final episode of PUMA’s RE:GEN REPORTS is now available to stream: ‘When it comes to Health and Safety, does the West know best?’. (Photo: Business Wire)
The podcast series aims to make PUMA’s 2022 Sustainability Report more accessible to a wider and younger audience. This came after research conducted last year which found that young people want brands to be more transparent with consumers when it comes to the environment and sustainability (34%) and to communicate their goals better (40%).
In 2022 PUMA hosted Conference of the People, where Gen Z representatives, PUMA’s industry peers, activists, NGOs, experts, ambassadors, and consumers met to discuss some of the fashion industry’s sustainability challenges. The conference also highlighted the need for PUMA to improve on how it was communicating sustainability goals, actions, and progress.
RE:GEN REPORTS is hosted by 10 next-generation thinkers from six countries, distilling the content of the brand’s sustainability report into 10 episodes. Each host was tasked with breaking down the complex topics into digestible pieces. Focusing on PUMA’s sustainability strategy FOREVER.BETTER. 10FOR25 sustainability targets, the podcasts were created to eliminate barriers of traditional sustainability language, explaining why the specific targets were a focus for the business. Episodes discuss progress that has been made, whilst acknowledging areas where there is still work to be done.
From a 147-page report and over thirty hours of recording came this 163-minute series of clear and relatable sustainability information. As well as the final episode on health and safety, young people guided audiences through episodes about: human rights, hosted by Award-winning activist, model, and social entrepreneur Anya Dillard from the USA; chemicals, hosted by sustainable and healthy living vlogger Luke Jaque-Rodney from Germany; circularity, hosted by USA-based upcycler Andrew Burgess; fair wages, hosted by Fair Labor Association student committee member Amina Shakeel; climate action, hosted by Earthero Project co-founder Bertha Shum from Hong Kong; biodiversity hosted by India-based environmental activist Ripudaman Bevli; plastic & oceans, hosted by Singapore sustainable bag company Peco Bag founder Yumika Hoskin; product, hosted by intersectional environmentalist Diandra Marizet from the US and water and air, hosted by Malaysian based eco-conscious Earth Day Ambassador Melissa Tan .
As well as PUMA spokespeople, the young hosts also interviewed representatives from industry bodies, businesses, and NGOs in discussions around the implementation and monitoring of more sustainable practices. Guests included Fair Labor Association’s Chief of Staff, Shelly Han; UNFCCC’s Sector’s Engagement in Climate Action Lead, Lindita Xhaferi-Salihu; Canopy’s Founder and Executive Director, Nicole Rycroft; ZDHC Implementation Director, Klass Nuttbohm; Apparel Impact Institute’s Chief Impact Officer, Kurt Kipka; and Leather Working Group’s Traceability Manager, Vanessa Brain.
“Transparency is critical to our sustainability strategy at PUMA,” says Anne-Laure Descours, Chief Sourcing Officer at PUMA. “We are committed to improving our practices and equally acknowledging where there is still a way for us to go. We invited these next generation thinkers to interview us and our partners on our FOREVER.BETTER. sustainability strategy 10FOR25 targets to push us to be better, to do better, and get into the detail in a way that more people can access and understand. It’s easy to hide areas where you’re not making progress as quickly as you’d like, but change requires collaboration and openness and with RE:GEN REPORTS we have and will continue to welcome both of those things.”
PUMA’s sustainability efforts have been recognized several times. In 2022, the brand topped the Business of Fashion sustainability ranking, the platform on living wage financials ranking, and the FTSE4Good ranking within its sectors. It was included in the Corporate Knights global top 100 most sustainable companies ranking, maintained its triple-A ranking with MSCI and its prime status with ISS; two leading sustainability rating agencies. Reuters also ranked it as number two within its sector and, in S&P sustainability benchmarking, PUMA outperformed all other sports brands for the first time since 2010. Although these rankings help confirm that PUMA is headed in the right direction with its FOREVER.BETTER. sustainability strategy, the brand recognizes that it still has a long way to go.
PUMA’s full 2022 Sustainability Report can be accessed here.
|
PUMA |
PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230801314932/en/
Contact information
Samantha Du Plessis - PUMA SE
Samantha.duplessis@puma.com
Lornette Harley – MSL
lornette.harley@mslgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom